Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000034.xml
Klin Padiatr 2013; 225(06): 352-353
DOI: 10.1055/s-0033-1355412
DOI: 10.1055/s-0033-1355412
Pictorial Essay
Multimodal Therapy of Recurrent Severe Acute Disseminated Encephalomyelitis: The Role of Immunoadsorption
Multimodale Therapie einer recurrenten schweren akuten disseminierten Enzephalomyelitis: Die Rolle der ImmunadsorptionFurther Information
Publication History
Publication Date:
28 October 2013 (online)
-
References
- 1 Elhassanien AF, Aziz HA. Acute demyelinating encephalomyelitis: Clinical characteristics and outcome. J Pediatr Neurosci 2013; 8: 26-30
- 2 Fernández Carbonell C, Chitnis T. Inflammatory demyelinating diseases in children: an update. Minerva Pediatr 2013; 65: 307-323
- 3 Greinacher A, Friesecke S, Abel P et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet 2011; 378: 1166-1173
- 4 Klingel R, Heibges A, Fassbender C. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies – perspectives for immunoadsorption. Atheroscler Suppl 2013; 14: 161-165
- 5 McDaneld LM, Fields JD, Bourdette DN et al. Immunomodulatory therapies in neurologic critical care. Neurocrit Care 2010; 12: 132-143
- 6 Pohl D, Tenembaum S. Treatment of acute disseminated encephalomyelitis. Curr Treat Options Neurol 2012; 14: 264-275